BACKGROUND: Cardiovascular diseases are prevalent in people with chronic obstructive pulmonary disease (COPD). We hypothesized that endothelial dysfunction could be a marker of the proatherogen status in COPD. METHODS AND RESULTS: We measured endothelial dysfunction by flow-mediated dilation (FMD) and after sublingual administration of nitroglycerin (nitrate-mediated dilation: NMD) in 44 COPD patients and 48 controls. Compared with controls COPD patients had worse mean FMD (5.4% vs 8.2%, P < .001) and NMD (12.0% vs 13.9%, P = .007). FMD was inversely related to FEV1/VC ratio (r = -0.327, P = .030). The negative association between COPD and FMD was confirmed after correction for potential confounders in a multiple linear regression model (beta = -0.019, P = .002). In the same model NMD (beta = 0.396, P < .001) was positively associated with FMD. CONCLUSIONS: Endothelial-dependent and, to a lesser extent, endothelial-independent dilations are significantly impaired in COPD, and the impairment is proportional to the severity of bronchial obstruction.
BACKGROUND:Cardiovascular diseases are prevalent in people with chronic obstructive pulmonary disease (COPD). We hypothesized that endothelial dysfunction could be a marker of the proatherogen status in COPD. METHODS AND RESULTS: We measured endothelial dysfunction by flow-mediated dilation (FMD) and after sublingual administration of nitroglycerin (nitrate-mediated dilation: NMD) in 44 COPDpatients and 48 controls. Compared with controls COPDpatients had worse mean FMD (5.4% vs 8.2%, P < .001) and NMD (12.0% vs 13.9%, P = .007). FMD was inversely related to FEV1/VC ratio (r = -0.327, P = .030). The negative association between COPD and FMD was confirmed after correction for potential confounders in a multiple linear regression model (beta = -0.019, P = .002). In the same model NMD (beta = 0.396, P < .001) was positively associated with FMD. CONCLUSIONS: Endothelial-dependent and, to a lesser extent, endothelial-independent dilations are significantly impaired in COPD, and the impairment is proportional to the severity of bronchial obstruction.
Authors: Katja Hueper; Jens Vogel-Claussen; Megha A Parikh; John H M Austin; David A Bluemke; James Carr; Jiwoong Choi; Thomas A Goldstein; Antoinette S Gomes; Eric A Hoffman; Steven M Kawut; Joao Lima; Erin D Michos; Wendy S Post; Ming Jack Po; Martin R Prince; Kiang Liu; Dan Rabinowitz; Jan Skrok; Ben M Smith; Karol Watson; Youbing Yin; Alan M Zambeli-Ljepovic; R Graham Barr Journal: Am J Respir Crit Care Med Date: 2015-09-01 Impact factor: 21.405
Authors: Pasquale Ambrosino; Roberta Lupoli; Salvatore Iervolino; Alberto De Felice; Nicola Pappone; Antonio Storino; Matteo Nicola Dario Di Minno Journal: Intern Emerg Med Date: 2017-06-07 Impact factor: 3.397
Authors: Gwenael Layec; Corey R Hart; Joel D Trinity; Oh-Sung Kwon; Matthew J Rossman; Ryan M Broxterman; Yann Le Fur; Eun-Kee Jeong; Russell S Richardson Journal: Am J Physiol Endocrinol Metab Date: 2017-03-14 Impact factor: 4.310
Authors: Anette S Fjeldstad; John McDaniel; Melissa A H Witman; Steve J Ives; Jia Zhao; John W Rose; James Hannon; D Walter Wray; Russell S Richardson Journal: J Neurol Date: 2011-05-05 Impact factor: 4.849
Authors: Divay Chandra; Aman Gupta; Patrick J Strollo; Carl R Fuhrman; Joseph K Leader; Jessica Bon; William A Slivka; Ali Hakim Shoushtari; Jennifer Avolio; Kevin E Kip; Steven Reis; Frank C Sciurba Journal: Am J Respir Crit Care Med Date: 2016-07-01 Impact factor: 21.405
Authors: Michael M Tymko; Justin S Lawley; Philip N Ainslie; Alexander B Hansen; Florian Hofstaetter; Simon Rainer; Sachin Amin; Gilbert Moralez; Christopher Gasho; Gustavo Vizcardo-Galindo; Daniela Bermudez; Francisco C Villafuerte; Christopher M Hearon Journal: Circ Res Date: 2020-04-09 Impact factor: 17.367
Authors: Andrew Cassar; Timothy I Morgenthaler; Charanjit S Rihal; Abhiram Prasad; Ryan J Lennon; Lilach O Lerman; Amir Lerman Journal: Coron Artery Dis Date: 2014-01 Impact factor: 1.439